Promotion of Wound Healing by an Agonist of Adenosine A2A Receptor Is Dependent on Tissue Plasminogen Activator

Inflammation

Volumn 38, Issue 6, 2015, Pages 2036-2041

  Montesinos, M Carmen ^a,b,c   Desai Merchant, Avani ^a   Cronstein, Bruce N ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

adenosine A2A receptors; animal models; plasminogen activator; wound healing

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; 2-(4-(2-CARBOXYETHYL)PHENETHYLAMINO)-5'-N-ETHYLCARBOXAMIDOADENOSINE; ADENOSINE; ADENOSINE A2 RECEPTOR AGONIST; PHENETHYLAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HISTIOCYTE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAST CELL; MOUSE; NONHUMAN; PLASMINOGEN ACTIVATION; QUALITY OF LIFE; WOUND CLOSURE; WOUND HEALING; WOUND HEALING IMPAIRMENT; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENETICS; INTRADERMAL DRUG ADMINISTRATION; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SKIN; TIME FACTOR; WOUNDS, PENETRATING;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; ADMINISTRATION, CUTANEOUS; ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HISTIOCYTES; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENETHYLAMINES; RECEPTOR, ADENOSINE A2A; SKIN; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; WOUND HEALING; WOUNDS, PENETRATING;

EID: 84946480318     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-015-0184-3     Document Type: Article

References (29)

1. Falanga, V. 2005. Wound healing and its impairment in the diabetic foot. Lancet 366(9498): 1736–1743.
2. Shen, Y., et al. 2012. Plasminogen is a key proinflammatory regulator that accelerates the healing of acute and diabetic wounds. Blood 119(24): 5879–5887.
3. Romer, J., et al. 1996. Impaired wound healing in mice with a disrupted plasminogen gene [see comments]. Nature Medicine 2(3): 287–292.
4. Simone, T.M., et al. 2014. SERPINE1: a molecular switch in the proliferation—migration dichotomy in wound-“activated” heratinocytes. Advance Wound Care (New Rochelle) 3(3): 281–290.
5. Fredholm, B.B., et al. 2011. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update. Pharmacological Reviews 63(1): 1–34.
6. Valls, M.D., B.N. Cronstein, and M.C. Montesinos. 2009. Adenosine receptor agonists for promotion of dermal wound healing. Biochemical Pharmacology 77(7): 1117–1124.
7. Haskó, G., and B.N. Cronstein. 2013. Regulation of inflammation by adenosine. Frontiers in Immunology 4: Article 85: 1–8. doi:10.3389/fimmu.2013.00085
8. Hasday, J.D., and R.G. Sitrin. 1987. Adenosine receptors on rabbit alveolar macrophages: binding characteristics and effects on cellular function. The Journal of Laboratory and Clinical Medicine 110: 264–273.
9. Sereda, M.J., P. Bradding, and C. Vial. 2011. Adenosine potentiates human lung mast cell tissue plasminogen activator activity. The Journal of Immunology 186(2): 1209–1217.
10. Hrafnkelsdottir, T., D. Erlinge, and S. Jern. 2001. Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man. Thrombosis and Haemostasis 85(5): 875–881.
11. Carmeliet, P., et al. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368(6470): 419–424.
12. Montesinos, M.C., et al. 2002. Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. The American Journal of Pathology 160(6): 2009–2018.
13. Victor-Vega, C., et al. 2002. Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel). Inflammation 26(1): 19–24.
14. Yotsu, R.R., et al. 2014. Comparison of characteristics and healing course of diabetic foot ulcers by etiological classification: neuropathic, ischemic, and neuro-ischemic type. Journal of Diabetes and its Complications 28(4): 528–535.
15. McBride, J., et al. 2014. Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signaling. The Journal of Investigative Dermatology 134: 1725–1734.
16. Fadini, G.P., et al. 2014. The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker. Diabetologia 57(9): 1947–1956.
17. Lund, I.K., et al. 2011. Concomitant lack of MMP9 and uPA disturbs physiological tissue remodeling. Developmental Biology 358(1): 56–67.
18. Grondahl-Hansen, J., et al. 1988. Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo. The Journal of Investigative Dermatology 90(6): 790–795.
19. Romer, J., et al. 1991. Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. The Journal of Investigative Dermatology 97(5): 803–811.
20. Toriseva, M. and V.M. Kahari. 2009. Proteinases in cutaneous wound healing. Cellular and Molecular Life Sciences 66(2): 203–224.
21. Lund, L.R., et al. 2006. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. Embo Journal 25(12): 2686–2697.
22. Bjorlin, G., and I.M. Nilsson. 1988. The effect of antifibrinolytic agents on wound healing. International Journal of Oral and Maxillofacial Surgery 17(4): 275–276.
23. Squadrito, F., et al. 2014. The effect of PDRN, an adenosine receptor A2A agonist, on the healing of chronic diabetic foot ulcers: results of a clinical trial. The Journal of Clinical Endocrinology and Metabolism 99(5): E746–E753.
24. Altavilla, D., et al. 2011. Activation of adenosine A2A receptors restores the altered cell-cycle machinery during impaired wound healing in genetically diabetic mice. Surgery 149(2): 253–261.
25. Romer, J., et al. 1994. The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds. The Journal of Investigative Dermatology 102(4): 519–522.
26. Weckroth, M., et al. 2004. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers. British Journal of Dermatology 151(6): 1189–1196.
27. Brodsky, S., et al. 2001. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis. American Journal of Physiology - Heart and Circulatory Physiology 281(4): H1784–H1792.
28. Montesinos, M.C. and M.D. Valls. 2010. Stimulation of wound revascularization by adenosine receptor activation. In Extracellular ATP and adenosine as regulators of endothelial cell Function, eds. E. Gerasimovskaya and E. Kaczmarek. 95–112. Springer.
29. Perez-Aso, M., et al. 2014. Adenosine 2A receptor promotes collagen production by human fibroblasts via pathways involving cyclic AMP and AKT but independent of Smad2/3. Faseb Journal 28(2): 802–812.